MDXG
NASDAQ · Biotechnology
Mimedx Group Inc
$4.12
-0.05 (-1.20%)
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+486.2% upside
Low Target
$19.42
Average Target
$24.15
High Target
$35.38
Current Price
$4.12
Current
$4.12
$4.12
Target
$24.15
$24.15
$19.42
$24.15 avg
$35.38
Scenario Analysis
Bear Case
$19.42
371.4%
Low target
Base Case
$24.15
+486.2%
Avg target
Bull Case
$35.38
+758.7%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$8.21
-49.8% from high
52-Week Low
$4.70
+-12.3% from low
Target vs 52W High
$24.15
+194.3% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 39 | 69% | $257.58 | +24.3% |
| AMGN | Hold | 42 | 50% | $190.87 | -46.1% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +162.3% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | -3.7% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -89.8% |
| ALNY | Strong Buy | 36 | 78% | $102.31 | -68.9% |
| INSM | Strong Buy | 26 | 92% | $143.40 | -3.3% |
| NTRA | Strong Buy | 27 | 89% | $142.91 | -27.6% |